Decoding Your OCT Scan: Beyond the Thickness Number
At a Glance
An OCT scan for diabetic macular edema shows more than retinal thickness: it reveals where fluid is located, whether the fovea is involved, and whether retinal layers, photoreceptors, or the vitreous may affect vision and treatment response.
When you look at an OCT (Optical Coherence Tomography) report, it may look like a topographical map or a cross-section of a cake. While it is easy to fixate on the overall thickness number, your retina specialist interprets the entire scan. They are looking for specific “biomarkers”—biological clues that give context to how healthy your retinal cells are and how you might respond to treatment [1][2].
The Central Question: Center-Involving DME
The most important distinction on your report is whether you have center-involving or non-center-involving DME.
- Center-Involving: This means fluid is present in the fovea, the very center of the macula (a 1-mm wide circle) [1]. If this swelling is accompanied by a drop in vision, it is often treated proactively with medications [3].
- Non-Center-Involving: Fluid is present in the macula but has not yet reached that central 1-mm zone [1]. Doctors often monitor this closely with frequent scans, or sometimes use localized laser therapy, to ensure it does not move toward the center [4].
Key Terms on Your Report
- Central Subfield Thickness (CST): This is the average thickness of the retina in that central 1-mm circle [1]. While thicker numbers indicate more fluid, there is no single, universal “normal” threshold across all OCT machines (a measurement on one brand of machine might differ from another) [5][6]. Diagnosis depends on the scan pattern, baseline anatomy, and your actual vision—not just a strict numeric cutoff.
- Intraretinal Fluid (IRF) and Cystoid Spaces: This is fluid that has leaked into the layers of the retina. It often forms cystoid spaces—tiny, fluid-filled bubbles. The presence of very large or numerous cysts can sometimes be a clue that the disease is more advanced [7][8].
- Subretinal Fluid (SRF): This is fluid sitting under the retina, lifting it up [7]. It is another marker of active leakage that your doctor will track during treatment [9].
Hidden Markers: Clues for Visual Potential
Beyond the fluid, your doctor looks at how “organized” your retinal layers appear. These markers are associations from clinical studies, not absolute predictions of your personal future—they simply help guide conversations about what to expect.
- DRIL (Disorganization of the Retinal Inner Layers): Normally, the inner layers of the retina look like distinct, parallel bands on the OCT. DRIL occurs when these bands become blurred and indistinguishable [10]. Extensive DRIL is often associated with a harder time recovering sharp vision, even after fluid goes away [11][12].
- EZ (Ellipsoid Zone) Integrity: The EZ is a bright line on the OCT representing the health of your photoreceptors (the cells that catch light). An intact EZ line is a very positive sign [13][14]. If this line is disrupted, it suggests some cellular stress, though it does not guarantee that vision loss is permanent [12].
When the “Goo” Pulls Back
Sometimes, the vitreous (the clear gel filling your eye) can interact with the macula.
- Vitreomacular Traction (VMT): This is when the gel is actively tugging on the macula, which can worsen the edema and sometimes complicate treatment [12].
- Epiretinal Membrane (ERM): This is a thin, scar-like film that can grow over the macula. If it begins pulling or wrinkling the retina, it can limit how much your vision improves, and may require separate attention [15][16].
The Completeness Checklist
When reviewing your OCT with your care team, you can use these categories to guide your questions:
- Fluid Location: Is the fluid center-involving or non-center-involving? [1]
- Structural Health: Do the inner layers look organized, or are there signs of DRIL? [10]
- Photoreceptor Integrity: Does the EZ (Ellipsoid Zone) line look relatively intact? [13]
- The Interface: Is there any pulling or membrane growth (VMT or ERM) affecting the macula? [12]
Common questions in this guide
What does center-involving DME mean on an OCT scan?
Does the CST number alone show how severe my DME is?
What do IRF, cystoid spaces, and SRF mean on my OCT report?
What do DRIL and the ellipsoid zone tell me about vision?
Can vitreomacular traction or an epiretinal membrane affect my DME?
Get notified when new evidence is published on diabetic macular edema.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (16)
- 1
Comparison of Central Macular Fluid Volume With Central Subfield Thickness in Patients With Diabetic Macular Edema Using Optical Coherence Tomography Angiography.
You QS, Tsuboi K, Guo Y, et al.
JAMA ophthalmology 2021; (139(7)):734-741 doi:10.1001/jamaophthalmol.2021.1275.
PMID: 33983385 - 2
Baseline OCT Biomarkers Associated with Visual Acuity in Diabetic Macular Edema: A Systematic Review and Meta-analysis.
Nanji K, Grad J, Hatamnejad A, et al.
Ophthalmology 2026; (133(1)):75-90 doi:10.1016/j.ophtha.2025.07.038.
PMID: 40803536 - 3
Diabetic Macular Edema: Traditional and Novel Treatment
Tomić M, Vrabec R, Poljičanin T, et al.
Acta clinica Croatica 2017; (56(1)):124-132 doi:10.20471/acc.2017.56.01.18.
PMID: 29120156 - 4
Evaluation of a combination digital retinal camera with spectral-domain optical coherence tomography (SD-OCT) that might be used for the screening of diabetic retinopathy with telemedicine: A pilot study.
Sanborn GE, Wroblewski JJ
Journal of diabetes and its complications 2018; (32(11)):1046-1050 doi:10.1016/j.jdiacomp.2018.08.010.
PMID: 30121204 - 5
INFLAMMATORY MEDIATORS IN DIABETIC MACULAR EDEMA: A Prospective, Controlled Study.
Kim SJ, Gangaputra S, Choi L, et al.
Retina (Philadelphia, Pa.) 2026; (46(9)):1513-1519 doi:10.1097/IAE.0000000000004893.
PMID: 42246764 - 6
Association Between Contrast Sensitivity and Central Subfield Thickness in Center-Involving Diabetic Macular Edema.
Baldwin G, Vingopoulos F, Zeng R, et al.
Journal of vitreoretinal diseases 2023; (7(3)):232-238 doi:10.1177/24741264231165611.
PMID: 37188217 - 7
Three-dimensional analysis of morphologic changes and visual outcomes in diabetic macular edema.
Lee H, Kang KE, Chung H, Kim HC
Japanese journal of ophthalmology 2019; (63(3)):234-242 doi:10.1007/s10384-019-00657-8.
PMID: 30783942 - 8
The Area and Number of Intraretinal Cystoid Spaces Predict the Visual Outcome after Ranibizumab Monotherapy in Diabetic Macular Edema.
Nagai N, Suzuki M, Uchida A, et al.
Journal of clinical medicine 2020; (9(5)) doi:10.3390/jcm9051391.
PMID: 32397232 - 9
OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant.
Zur D, Iglicki M, Busch C, et al.
Ophthalmology 2018; (125(2)):267-275 doi:10.1016/j.ophtha.2017.08.031.
PMID: 28935399 - 10
Neural Retinal Disorganization as a Robust Marker of Visual Acuity in Current and Resolved Diabetic Macular Edema.
Sun JK, Radwan SH, Soliman AZ, et al.
Diabetes 2015; (64(7)):2560-70 doi:10.2337/db14-0782.
PMID: 25633419 - 11
OCT outcomes as biomarkers for disease status, visual function, and prognosis in diabetic macular edema.
Velaga SB, Nittala MG, Alagorie AR, et al.
Canadian journal of ophthalmology. Journal canadien d'ophtalmologie 2024; (59(2)):109-118 doi:10.1016/j.jcjo.2023.01.012.
PMID: 36803932 - 12
Optical Coherence Tomography Biomarkers in Bilateral Diabetic Macular Edema Patients with Asymmetric anti-VEGF Response.
Koc F, Güven YZ, Egrilmez D, Aydın E
Seminars in ophthalmology 2021; (36(5-6)):444-451 doi:10.1080/08820538.2021.1907423.
PMID: 33780313 - 13
Disorganization of inner retinal layers and disruption of outer retinal layers as predictors of anti-vascular endothelial growth factor treatment outcomes in diabetic macular edema: A scoping review.
Nadimpalli S, Vijendran S, Bhandary SV
Survey of ophthalmology 2026; (71(6)):1653-1664 doi:10.1016/j.survophthal.2026.05.005.
PMID: 42176958 - 14
External limiting membrane: retinal structural barrier in diabetic macular edema.
Saxena S, Akduman L, Meyer CH
International journal of retina and vitreous 2021; (7(1)):16 doi:10.1186/s40942-021-00284-x.
PMID: 33663592 - 15
A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment.
Hsieh TC, Deng GH, Chang YC, et al.
Frontiers in endocrinology 2023; (14()):1108097 doi:10.3389/fendo.2023.1108097.
PMID: 37265702 - 16
Early visual response provides additional prognostic value beyond baseline OCT features in diabetic macular edema.
Kaplan FB, Tokuç EÖ, Bozkurt E, et al.
European journal of ophthalmology 2026; 11206721261480211 doi:10.1177/11206721261480211.
PMID: 42630057
This page explains how OCT findings are used in diabetic macular edema for educational purposes and does not replace medical advice. Your retina specialist should interpret your scan and recommend care for your situation.